wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24658506-259B3A53-979B-498F-AD94-247E73DE174A
Q24658506-259B3A53-979B-498F-AD94-247E73DE174A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24658506-259B3A53-979B-498F-AD94-247E73DE174A
Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study
P2860
Q24658506-259B3A53-979B-498F-AD94-247E73DE174A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24658506-259B3A53-979B-498F-AD94-247E73DE174A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da23e308b557708e6492af8199e9d4437ef84cd5
P2860
Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.